Dataset Information


Synthesis and evaluation of polymeric micelle containing piperacillin/tazobactam for enhanced antibacterial activity.

ABSTRACT: Infections caused by multidrug-resistant bacteria such as P. aeruginosa are important therapeutic complications. Piperacillin/Tazobactam is considered a safe antimicrobial agent. But we should not ignore the prevalence of resistant strains to this drug. In this work, a new polymeric micelle composed of Piperacillin/Tazobactam-loaded Poly (ethylene glycol) methyl ether-block-poly (lactide-co-glycolide) (PLGA-PEG) was developed to improve the antimicrobial performance of P/T. The SEM and TEM studies of PLGA-PEG micelle showed, semi-spherical morphology with a mean diameter of below 30?nm. Zeta potential results indicated that the surface charge of PLGA-PEG micelle was -2.98?mV, while after encapsulation of P/T, the surface charge decreases to -4.13?mV. Clinical strains of P. aeruginosa were isolated and their resistance pattern against different antibiotics was evaluated. The MIC of free and P/T -Loaded PLGA-PEG micelles was determined. Also, the effect of free or P/T micelle against minimal biofilm eradication concentration and motility inhibition was evaluated. The bacterial isolates were resistant to most common antibiotics. The MIC of the free drug form and micelle form ranged from 4 to 512?µg/ml and 2 to 256?µg/ml, respectively. Generally, micelle showed more effective antibiofilm activities, inhibition of bacterial motility and reducing the MIC than that free drug form.


PROVIDER: S-EPMC6896493 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7526819 | BioStudies
2017-01-01 | S-EPMC5309263 | BioStudies
2016-01-01 | S-EPMC4819271 | BioStudies
2005-01-01 | S-EPMC1308815 | BioStudies
1000-01-01 | S-EPMC2945087 | BioStudies
2002-01-01 | S-EPMC128712 | BioStudies
1000-01-01 | S-EPMC4018813 | BioStudies
2014-06-12 | E-GEOD-58390 | ArrayExpress
2019-01-01 | S-EPMC6790397 | BioStudies
2019-01-01 | S-EPMC6811421 | BioStudies